Intrinsic Value

The intrinsic value of Avricore Health Inc (8VP1) under the Base Case is 0.003 EUR per share. Compared with the current market price of 0.023 EUR, the stock appears Overvalued by 88% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

8VP1 Intrinsic Value
€0.003
Overvaluation 88%
Intrinsic Value
Price €0.023

8VP1 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor 8VP1
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0
Get notified when the price drops into your buy zone
Current Price €0.02
Intrinsic Value €0
Margin of Safety 20% €0
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 8VP1

Fundamental Analysis

What Avricore Health Does

Health Care

Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues.

Headquarters
Canada CA
Employees
25
IPO date
Jul 31, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Avricore Health Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 8VP1 stock?

The intrinsic value for Avricore Health Inc (8VP1) under the Base Case is 0.003 EUR.

Is 8VP1 stock undervalued or overvalued?

Compared with the current market price of 0.023 EUR, the stock appears Overvalued by 88% .

Back to Top